AI assistant
Sending…
Allogene Therapeutics, Inc. — Director's Dealing 2021
Aug 23, 2021
33378_dirs_2021-08-23_8c99ee17-e30f-4014-ac72-3fba576f4c6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Allogene Therapeutics, Inc. (ALLO)
CIK: 0001737287
Period of Report: 2021-08-20
Reporting Person: WITTE OWEN N. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-20 | Common Stock | S | 5000 | $23.70 | Disposed | 231182 | Direct |
| 2021-08-20 | Common Stock | S | 5000 | $23.24 | Disposed | 226182 | Direct |
More from Allogene Therapeutics, Inc.
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 4
Major Shareholding Notification
2026
Feb 17